Clorox Co (NYSE:CLX) COO Dawn C. Willoughby sold 25,950 shares of the firm’s stock in a transaction that occurred on Tuesday, December 4th. The stock was sold at an average price of $164.59, for a total transaction of $4,271,110.50. Following the sale, the chief operating officer now owns 32,409 shares of the company’s stock, valued at approximately $5,334,197.31. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Clorox stock traded down $1.29 during mid-day trading on Friday, reaching $162.47. The company’s stock had a trading volume of 808,824 shares, compared to its average volume of 855,589. Clorox Co has a 12-month low of $113.57 and a 12-month high of $167.70. The firm has a market capitalization of $20.90 billion, a price-to-earnings ratio of 25.95, a P/E/G ratio of 4.02 and a beta of 0.30. The company has a current ratio of 1.07, a quick ratio of 0.65 and a debt-to-equity ratio of 3.38.
Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 31st. The company reported $1.62 earnings per share for the quarter, beating analysts’ consensus estimates of $1.59 by $0.03. Clorox had a net margin of 13.59% and a return on equity of 102.65%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same period in the previous year, the business earned $1.46 EPS. Clorox’s revenue was up 4.2% compared to the same quarter last year. On average, equities research analysts forecast that Clorox Co will post 6.31 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 8th. Investors of record on Wednesday, January 23rd will be paid a $0.96 dividend. The ex-dividend date of this dividend is Tuesday, January 22nd. This represents a $3.84 dividend on an annualized basis and a yield of 2.36%. Clorox’s dividend payout ratio is 61.34%.
A number of institutional investors have recently added to or reduced their stakes in CLX. Morgan Stanley grew its stake in Clorox by 178.2% in the 3rd quarter. Morgan Stanley now owns 3,063,813 shares of the company’s stock valued at $460,828,000 after buying an additional 1,962,433 shares in the last quarter. Macquarie Group Ltd. grew its stake in Clorox by 437,400.0% in the 2nd quarter. Macquarie Group Ltd. now owns 1,750,000 shares of the company’s stock valued at $236,688,000 after buying an additional 1,749,600 shares in the last quarter. Schroder Investment Management Group grew its stake in Clorox by 57.0% in the 2nd quarter. Schroder Investment Management Group now owns 1,506,358 shares of the company’s stock valued at $201,641,000 after buying an additional 547,070 shares in the last quarter. FMR LLC grew its stake in Clorox by 201.0% in the 2nd quarter. FMR LLC now owns 472,179 shares of the company’s stock valued at $63,863,000 after buying an additional 315,298 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale grew its stake in Clorox by 110.5% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 427,013 shares of the company’s stock valued at $61,991,000 after buying an additional 224,143 shares in the last quarter. Institutional investors and hedge funds own 77.96% of the company’s stock.
Several brokerages have recently issued reports on CLX. Zacks Investment Research lowered shares of Clorox from a “hold” rating to a “sell” rating in a research note on Monday, December 3rd. Bank of America restated a “neutral” rating and set a $170.00 price target (up previously from $150.00) on shares of Clorox in a research note on Thursday. Citigroup raised their price target on shares of Clorox from $153.00 to $169.00 and gave the stock a “hold” rating in a research note on Tuesday, November 20th. Barclays set a $138.00 price target on shares of Clorox and gave the stock a “hold” rating in a research note on Thursday, November 1st. Finally, BMO Capital Markets raised their price target on shares of Clorox from $153.00 to $165.00 and gave the stock a “buy” rating in a research note on Friday, November 2nd. Five equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $144.93.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Equities Focus and is owned by of Equities Focus. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.equitiesfocus.com/2018/12/08/clorox-co-clx-coo-dawn-c-willoughby-sells-25950-shares-of-stock.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: Cost of equity and a company’s balance sheet
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.